Archives
-
Exciting news as o2h Ventures’ portfolio company Small Pharma, unveils positive top-line results of their Phase IIa clinical trial for treating MDD 31 January, 2023
-
o2h Ventures backed Kuano wins Innovate UK funding for designing the next generation of cancer drugs 18 January, 2023
-
o2h Ventures invests in Qkine – once again… 22 December, 2022
-
o2h Ventures backed Turbine raises €20 Million 30 November, 2022
-
Alevin Therapeutics won the Best Biotech Start-up at the OBN Awards 2022 18 November, 2022
-
o2h Ventures backed Neurofenix raises $7 Million to transform stroke and brain injury recovery 06 September, 2022
-
Funding boost for spin-out developing new medicines for life-threatening diseases 29 July, 2022
-
o2h Ventures makes an SEIS investment into CardiaTec 06 July, 2022
-
o2h Ventures backed Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer 14 June, 2022